Rockefeller Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-3,771
| Closed | -$2K | – | 2021 |
|
|
2022
Q4 | $2K | Hold |
3,771
| – | – | ﹤0.01% | 3532 |
|
|
2022
Q3 | $1K | Hold |
3,771
| – | – | ﹤0.01% | 3661 |
|
|
2022
Q2 | $1K | Hold |
3,771
| – | – | ﹤0.01% | 3893 |
|
|
2022
Q1 | $2K | Buy |
3,771
+1,900
| +102% | +$1.01K | ﹤0.01% | 3574 |
|
|
2021
Q4 | $4K | Hold |
1,871
| – | – | ﹤0.01% | 3323 |
|
|
2021
Q3 | $5K | Hold |
1,871
| – | – | ﹤0.01% | 3152 |
|
|
2021
Q2 | $7K | Buy |
+1,871
| New | +$7K | ﹤0.01% | 2903 |
|
|
2020
Q4 | – | Sell |
-413
| Closed | -$1K | – | 2840 |
|
|
2020
Q3 | $1K | Buy |
413
+157
| +61% | +$380 | ﹤0.01% | 2444 |
|
|
2020
Q2 | $3K | Sell |
256
-167
| -39% | -$1.96K | ﹤0.01% | 2202 |
|
|
2020
Q1 | $3K | Buy |
+423
| New | +$3K | ﹤0.01% | 2069 |
|